These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28501294)

  • 1. Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedure.
    van der Lee JH; Morton J; Adams HR; Clarke L; Ebbink BJ; Escolar ML; Giugliani R; Harmatz P; Hogan M; Jones S; Kearney S; Muenzer J; Rust S; Semrud-Clikeman M; Wijburg FA; Yu ZF; Janzen D; Shapiro E
    Mol Genet Metab; 2017 Jun; 121(2):70-79. PubMed ID: 28501294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy development for the mucopolysaccharidoses: Updated consensus recommendations for neuropsychological endpoints.
    van der Lee JH; Morton J; Adams HR; Clarke L; Eisengart JB; Escolar ML; Giugliani R; Harmatz P; Hogan M; Kearney S; Muenzer J; Muschol N; Rust S; Saville BR; Semrud-Clikeman M; Wang R; Shapiro E
    Mol Genet Metab; 2020; 131(1-2):181-196. PubMed ID: 32917509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: A review of the literature.
    Janzen D; Delaney KA; Shapiro EG
    Mol Genet Metab; 2017 Jun; 121(2):57-69. PubMed ID: 28506702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of neurocognition in MPS disorders: A review.
    Shapiro EG; Eisengart JB
    Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses.
    Frawley G; Fuenzalida D; Donath S; Yaplito-Lee J; Peters H
    Paediatr Anaesth; 2012 Aug; 22(8):737-44. PubMed ID: 22381044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses.
    Barone R; Pellico A; Pittalà A; Gasperini S
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):121. PubMed ID: 30442188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread abnormalities of radiocolloid distribution in patients with mycopolysaccharidoses.
    Klingensmith WC; Eikman EA; Maumenee I; Wanger HN
    J Nucl Med; 1975 Nov; 16(11):1002-6. PubMed ID: 810547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mucopolysaccharidoses. Apropos of 25 cases in 17 families].
    Trabelsi M; Ben Dridi MF; Gharbi HA; Tabbane C; Ben Osman R
    Tunis Med; 1986 Jan; 64(1):49-56. PubMed ID: 3087042
    [No Abstract]   [Full Text] [Related]  

  • 10. Further electroretinographic studies of patients with mucopolysaccharidoses.
    Leung LS; Weinstein GW; Hobson RR
    Birth Defects Orig Artic Ser; 1971 Mar; 7(3):32-40. PubMed ID: 5006141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of brain disease in the mucopolysaccharidoses.
    Scarpa M; Orchard PJ; Schulz A; Dickson PI; Haskins ME; Escolar ML; Giugliani R
    Mol Genet Metab; 2017 Dec; 122S():25-34. PubMed ID: 29153844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III.
    Ghosh A; Shapiro E; Rust S; Delaney K; Parker S; Shaywitz AJ; Morte A; Bubb G; Cleary M; Bo T; Lavery C; Bigger BW; Jones SA
    Orphanet J Rare Dis; 2017 Jun; 12(1):117. PubMed ID: 28651568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessments of neurocognitive and behavioral function in the mucopolysaccharidoses.
    Shapiro EG; Escolar ML; Delaney KA; Mitchell JJ
    Mol Genet Metab; 2017 Dec; 122S():8-16. PubMed ID: 29128371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families.
    Malcolm C; Hain R; Gibson F; Adams S; Anderson G; Forbat L
    Acta Paediatr; 2012 Sep; 101(9):985-92. PubMed ID: 22452449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study.
    Hoffmann F; Hoffmann S; Kunzmann K; Ries M
    Orphanet J Rare Dis; 2020 Oct; 15(1):275. PubMed ID: 33008435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging drugs for the treatment of mucopolysaccharidoses.
    Giugliani R; Federhen A; Vairo F; Vanzella C; Pasqualim G; da Silva LM; Giugliani L; de Boer AP; de Souza CF; Matte U; Baldo G
    Expert Opin Emerg Drugs; 2016; 21(1):9-26. PubMed ID: 26751109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying the functional independence measure to the assessment of patients with mucopolysaccharidosis.
    Almeida Matos M; Silva Lopes P; Rodrigues Corsini A; Rodi J; Fong CT
    Colomb Med (Cali); 2020 Sep; 51(3):e213996. PubMed ID: 33402755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.
    Pan D
    Curr Pharm Biotechnol; 2011 Jun; 12(6):884-96. PubMed ID: 21235445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical management of behavioral problems in mucopolysaccharidoses disorders.
    Escolar ML; Jones SA; Shapiro EG; Horovitz DDG; Lampe C; Amartino H
    Mol Genet Metab; 2017 Dec; 122S():35-40. PubMed ID: 29170079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.